Outlook Therapeutics OTLK
NASDAQ OTLK
$0.59 +0.02 (+3.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Interest & Investment Income (2023 - 2024)

Updated

Outlook Therapeutics (OTLK) posted Interest & Investment Income of $89,738 for FY2025 (year ended Sep 30, 2025), down 90.1% from $906,150 in FY2024.

Analysis

Outlook Therapeutics (OTLK) Interest & Investment Income (2023 - 2024) Analysis & Trends

  • Business Quant data shows OTLK's Interest & Investment Income at $906,150 in FY2024 (-6.7%) and $971,480 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Outlook Therapeutics 80.68 Mn 44.93 Mn -8,265.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 239,951.00
Jun 30, 2024 404,593.00
Sep 30, 2023 306,021.00
Jun 30, 2023 395,537.00
API Access

Outlook Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=OTLK&period=max&api_key=YOUR_API_KEY